share_log

Axsome Therapeutics, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Benzinga ·  Dec 30, 2024 21:13

U.S. stock futures were lower this morning, with the Dow futures falling more than 50 points on Monday.

Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) fell sharply in today's pre-market trading after the announced completion and results of Phase 3 clinical program of AXS-05 in Alzheimer's Disease Agitation.

Axsome Therapeutics shares fell 8.9% to $79.00 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

  • Intchains Group Limited (NASDAQ:ICG) fell 10.3% to $8.37 in pre-market trading after jumping 53% on Friday.
  • MRC Global Inc. (NYSE:MRC) shares dipped 9.7% to $11.41 in pre-market trading. MRC Global will release its fourth quarter results after the closing bell on Feb. 11, 2025.
  • Peakstone Realty Trust (NYSE:PKST) fell 7.8% to $10.21 in pre-market trading.
  • CARGO Therapeutics, Inc. (NASDAQ:CRGX) shares declined 7.4% to $13.10 in pre-market trading following a 5% decline on Friday.
  • Arqit Quantum Inc. (NASDAQ:ARQQ) fell 7.4% to $39.53 in pre-market trading.
  • SEALSQ Corp (NASDAQ:LAES) dipped 6.7% to $8.47 in pre-market trading after gaining around 4% on Friday.
  • Pediatrix Medical Group, Inc. (NYSE:MD) shares slipped 6.5% to $12.61 in pre-market trading after declining around 1.8% on Thursday.
  • MasterCraft Boat Holdings, Inc. (NASDAQ:MCFT) declined 3.1% to $18.14 in pre-market trading.
  • Tesla, Inc. (NASDAQ:TSLA) shares fell 1.5% to $425.19 in pre-market trading following a 5% decline on Friday. Tesla said on Saturday that the company will reduce benefits as part of its referral program in North America starting next year.

Now Read This:

  • How To Earn $500 A Month From RPM International Stock Ahead Of Q2 Earnings
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment